The management of patient with suspected or known cardiac glycoside poisoning is complicated by variable time in course in toxicity, unpredictable dose response relationship, and requirement for interhospital. Although digoxin specific antibody fragments are safe and effective, randomised trials have not been performed. Increased intracellular calcium increases cardiac contractility, but also the risk of tachyarrhythmias. Mechanisms, manifestations, and management of digoxin. Introduction one of top toxins in the world because of the wide availability of digoxin and a narrow therapeutic window. Toxicity causes anorexia, nausea, vomiting and neurological symptoms. Its corresponding aglycone is digoxigenin, and its acetyl derivative is acetyldigoxin it is widely used in the treatment of various heart conditions namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be. Digoxin overdose symptoms, diagnosis and treatment bmj. It is advised to discuss management of patients with digoxin toxicity with the uk national poisons information service at the following contact phone number. Conversely, hyperkalemia diminishes digoxins effectiveness. Digoxin toxicity the college of family physicians of canada.
Digoxin is a medicine that is used to treat heart failure or arrhythmias abnormal heart rhythms. The most important step in the management of toxicity due to any of the cardiac glycosides is its recognition. Both the current canadian guidelines for heart failure and atrial fibrillation and the american college of cardiology foundationamerican heart association guideline for the management of heart failure include digoxin as a treatment option. Recommendations regarding the use of digoxin in the management of heart failure or arrhythmias are discussed separately. Digoxinspecific fab fragments digibind is the definitive treatment, toxicity is refractory standard dysrhythmia treatments. The use of digitalis genus plants was first described in 1785 by british physician dr. The toxicity range from understandable symptoms like nausea, vomiting, palpitations to various nonspecific symptoms. About digoxin it is a purified cardiac glycoside extracted from the foxglove plant, digitalis lanata. Mechanisms, manifestations, and management of digoxin toxicity.
Hypercalcaemia and hyperkalemia increase risk of digitalis induced arrhythmias. Signs and symptoms of lifethreatening or potentially lifethreatening digoxin also known as digitalis toxicity include, but are not limited to, severe ventricular arrhythmias including ventricular tachycardia or fibrillation, progressive bradycardia, second or thirddegree heart block not responsive to atropine, serum potassium levels. Moreserious evidence oftoxicity, particularly with cardiac involvement, requires admission to. Digoxin also causes an increase in vagal activity, reducing activity in the. A 45yearold man in sinus rhythm, with an ejection fraction of 20%, normal coronaries, and normal renal function is receiving captopril 50 mg 3 times daily, carvedilol 25 mg and furosemide 40 mg twice daily, and spironolactone 25 mg daily. Background although the use of digoxin in heart failure management has declined, toxicity remains a prevalent complication. Sinoatrial disorders digoxin may worsen sinus bradycardia or sa block. Infusionrelated or hypersensitivity reactions are possible. William withering, for the treatment of edema dropsy and other peculiar conditions 11.
Digoxin immune fab is indicated for the treatment of life threatening digoxin toxicity in patients with manifestations of severe toxicity. The most common ecg finding in digitalis toxicity is premature ventricular contractions pvcs ive included a table from fisch and knoebel that nicely categorizes the rest of ecg findings with digitalis toxicity. Chronic digoxin toxicity varies in severity but is associated with a mortality at one week of 1530%. With hypocalcemia the use of digoxin may be ineffective. Digoxin immune fab digifab management of digoxin toxicity. Data on the indications for digoxin therapy, evidence of toxicity and timing of the blood samples relative to administration of the last digoxin dose were. The management and monitoring the digoxin toxicity is still a challengin g in some places due to lack of proper evidencebased guidelines. Digoxin toxicity is managed according to the information presented in box 811.
As digoxin is now the only cardiac glycoside available in most countries, the method of initiating therapy with digoxin for patients with atrial fibrillation is presented here. Toxicity may occur with plasma digoxin levels within therapeutic range, especially in chronic overdose. This drug must be taken according to the prescription of the physician because taking too much of this drug may lead to toxicity and produce undesirable symptoms 1, 2. Digoxin generally does not have a role in the treatment of diastolic heart failure and is not a firstline therapy for managing atrial fibrillation in patients with heart failure. Digoxin gloucestershire hospitals nhs foundation trust. Objectives this study was developed to determine contemporary management of digoxin toxicity and clinical outcomes. Approximately 90% adult patients with proven digoxin toxicity have serum digoxin levels greater than 2. Toxicity risk assessment management ingestion of 10 mg a serious toxicity decontamination. Emergency department management of calciumchannel blocker. Noncardiac signs are nausea, vomiting, diarrhoea, anorexia, fatigue and less commonly neurological symptoms. Monitor patients for signs and symptoms of anaphylaxis and acute allergic reaction. Serum digoxin level with a therapeutic range in serum at 0.
Management of digoxin toxicity when the toxic effects of digoxin are associated with hypokalemia, the hydroelectrolytic imbalance can be corrected by intravenous perfusion of potassium chloride 40mmoll per hour, with electrocardiographic monitoring. Digoxin toxicity is a clinical diagnosis that relies in part on ecg findings such as signs of increased automaticity and av node blockade pvcs, slowed ventricular response. Hyperkalemia can be corrected only by using digoxinspeci. It can occur even when the serum digoxin concentration is within the therapeutic range.
Digoxin increases intracellular calcium in myocardial cells indirectly, by inhibiting the sodiumpotassium pump in the cell membrane. The nurse can ask if the doctor has called the poison center or toxicologist yet. Methods the premier perspective comparative hospital database premier inc. Capitals indicate lifethreatening, underlines indicate most frequent. It also reduces the conductivity of the heart through the atrioventricular av node. Pharmacokinetic aspects of digoxin specific fab therapy in the management of digitalis toxicity.
The dosing of digoxinspecific antibody fab fragments for the treatment of digoxin toxicity and the therapeutic use of digoxin are discussed separately. It is often difficult to diagnose patients with digoxin toxicity because it is difficult to distinguish whether the signs, symptoms and ecg changes are due to digoxin toxicity or underlying disease condition 3,4. If the evidence of toxicity is relatively minor with, for example, symptoms of nausea, with drawal of the drug is often the only specific treatment required. Based on the beers criteria, which strongly recommend against taking more than 0. Digoxin is a complex drug and has a lot of different effects on the heart electrophysiology, which leads to variable ecg findings. Digoxin is a medication prescribed to patients with cardiac problems.
Amr mohamed abdelmonem elsharkawy critical care resident physician alexandria main university hospital 2. Hypokalaemia and hypomagnesaemia may increase risk of toxicity. Coarse atrial fibrillation with 3rd degree av block and a junctional escape rhythm. Following the advent of isolation of digoxin from the. Certain medical conditions such as kidney disease, hypothyroidism. Despite the development of an accurate clinical assay for serum levels of digoxin 20 years ago, digitalis toxicity remains common and difficult to confirm, even if. Ppt digoxin powerpoint presentation free to view id. The poison center or toxicologist should be consulted for further management recommendations regarding digoxin toxicity. Hemoperfusion in the management of digoxin toxicity jama. Digoxin toxicity may be added to the list of conditions that can be treated by this method.
Digoxin toxicity symptoms, signs, level, treatment. Cardiac signs are arrhythmias secondary to increased intracellular calcium. Digoxin toxicity is clearly characterized when ventricular extrasystoles and atrioventricular block are associated symptoms. Digoxin also exerts direct action on vascular smooth muscle and indirect effects mediated primarily by the autonomic. Digoxin immune fab is not always required in the management of chronic digoxin poisoning. It is worthy of note that these manifestations are enhanced by preexisting factors such as age, cardiomyopathies, plasma concentration of digitalis, and hyperkalemia 6. Digoxin is a cardiac glycoside which has positive inotropic activity characterized by an increase in the force of myocardial contraction. Review article diagnosis and treatment ofdigoxintoxicity.
There are no evidencebased guidelines for the management of mild to moderate toxicity so there is a wide variation in treatment. In considering the emergent management of digoxin toxicity, keep in mind that the relationship between digoxin toxicity and the serum digoxin level is complex. Digoxin toxicity, also known as digoxin poisoning, is a type of poisoning that occurs in people who take too much of the medication digoxin or eat plants such as foxglove that contain a similar substance. Digoxin in the management of cardiovascular disorders.
Clinical practices for assessing serum digoxin toxicity. Digoxin toxicity litfl medical blog ecg library toxicology. Instruct parents or caregivers in apical heart rate assessment. Despite these therapies, he continues to complain of dyspnea with minimal exertion. It is not indicated for mild cases of digoxin toxicity or in cases of elevated serum digoxin concentrations in the absence of signs and symptoms of digoxin toxicity. Cellulosecoated activated charcoal was used in another patient who had ingested a massive dose of digoxin. Gastrointestinal and cns symptoms improved, and seconddegree heart block with lifethreatening bradycardia cleared during hemoperfusion. Toxicity risk assessment management toxicity is often precipitated by other pathological treat the underlying cause and withhold negative inotropicchronotropic agents processes e. Digoxin is one of the oldest cardiac medications still in use. Admit to the micu for continued critical care monitoring and reassessment. Digoxin immune fab is not always required in the management of acute digoxin poisoning. Digoxin immune fab therapy in the management of digitalis intoxication. Although digoxinspecific antibody fragments are safe and effective, randomised trials have not been performed. Patients at highest risk for digoxin toxicity include those with renal insufficiency, heart failure, and dehydration.
1500 487 125 909 1387 1537 1031 1386 1000 861 1314 433 261 582 554 1569 1521 436 1003 1080 477 323 262 1229 304 1164 552 1201 675 1085 196 1086 756 385 681 1371 1013 682 937 106 151 1492 688